Breaking News

Merck Licenses Bend’s Research Technology

Aims to solve complex formulation and process-development problems

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Bend Research has entered into a licensing agreement with Merck, under which Bend Research will provide Merck access to its spray-dried dispersion (SDD) technology. If needed, Bend may also provide Merck with access to additional drug-delivery platforms and intellectual property, including modified-release technologies and drug-discovery formulation tools. The two companies will use their scientific and engineering capabilities in an effort to solve complex formulation and process-development p...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters